Frank Ruffo, Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS), sold 27,624 shares at $22.30 ($596K) on 2021-06-02, disclosed to the SEC on 2021-06-02.
Open-market sale of $596k ACRS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.51 | 12,587 | $271K | 45.4% |
| 2 | $21.51 | 12,587 | $271K | 45.4% |
| 3 | $22.30 | 2,450 | $55K | 9.2% |
| Total | $21.58 avg | 27,624 | $596K | 100% |
| Filing → |
| ACRS | SELL | 2021-04-26 | $3.0M | — | Filing → |
| ACRS | BUY | 2018-05-07 | $23K | — | Filing → |
| ACRS | BUY | 2018-04-09 | $21K | — | Filing → |